The Gut-Thyroid Axis: How Your Gut Health Shapes Your Thyroid Function

If you have Hashimoto’s thyroiditis, hypothyroidism, or a thyroid condition that feels stubborn despite treatment, there’s a good chance no one has talked to you about your gut. That oversight might be costing you your health. Over the last decade, a growing body of research has established what is now called the gut-thyroid axis — a bidirectional communication network between your intestines and your thyroid gland. Put simply: your gut influences your thyroid, and your thyroid influences your gut. When either goes wrong, the other suffers. Understanding this connection is, in my view, one of the most important — and most overlooked — frontiers in thyroid health.

In this post I’m going to walk you through exactly how this connection works, what can go wrong, and what you can do about it.

What Is the Gut-Thyroid Axis?

The gut-thyroid axis refers to the two-way relationship between the gastrointestinal tract and the thyroid gland. This includes:

• The intestinal barrier (the lining of your gut)
• The gut microbiome (the trillions of microorganisms living in your intestines)
• The absorption of thyroid hormones and the nutrients needed to make them
• Immune system activity that originates in the gut but can affect the thyroid

Think of it less like a simple on/off switch and more like a complex conversation. The state of your gut directly influences how well your thyroid works — and vice versa.

Your Gut Lining: The Gatekeeper

Your intestinal lining is a single layer of cells, just one cell thick, separating the contents of your gut from your bloodstream. It acts as a highly selective barrier — allowing nutrients, water and hormones to pass through, while keeping out pathogens (disease-causing microbes), toxins, and incompletely digested food particles.

The junctions between these cells — known as tight junctions — are the gatekeepers. When they are working properly, only what should cross does cross. When they become disrupted, the barrier becomes “leaky.” You may have heard this referred to as leaky gut, or in clinical terms, increased intestinal permeability.

When the gut barrier is compromised, harmful bacterial products — including a molecule called lipopolysaccharide (LPS), which is found on the outer wall of certain bacteria — can get into the bloodstream. LPS is highly inflammatory. Once it enters circulation, it can activate the immune system, disrupt thyroid hormone production, and contribute to autoimmune processes.

One important marker of leaky gut is a protein called zonulin. Research has found that zonulin levels are significantly elevated in people with Hashimoto’s thyroiditis, strongly suggesting that intestinal barrier dysfunction plays a role in the development of this condition.

The Gut Microbiome and Thyroid Disease

Your gut microbiome — the vast community of bacteria, viruses, fungi and other microorganisms living in your intestines — plays a central role in immune regulation, nutrient absorption, inflammation control, and thyroid hormone metabolism. When this community is balanced, it supports health. When it becomes imbalanced — a state called dysbiosis — problems follow.

What Does Dysbiosis Look Like in Thyroid Disease?

Multiple studies have now compared the gut microbiomes of people with Hashimoto’s thyroiditis against healthy individuals. The pattern is consistent:

Bacteria that tend to decrease in Hashimoto’s:

• Faecalibacterium prausnitzii — a key producer of a beneficial compound called butyrate (more on this shortly)
• Lactobacillus and Bifidobacterium — well-known beneficial bacteria
• Prevotella and Lachnoclostridium

Bacteria that tend to increase in Hashimoto’s:

• Gram-negative, pro-inflammatory bacteria that carry LPS
• Enterobacteriaceae, Bacteroides fragilis

In Graves’ disease (an autoimmune condition causing an overactive thyroid), a similar pro-inflammatory shift occurs, with reductions in beneficial Faecalibacterium and increases in LPS-carrying Bacteroides, Enterobacter, and Chryseobacterium.

The picture emerging across thyroid conditions is consistent: a loss of bacteria that produce anti-inflammatory compounds, and a relative enrichment of bacteria that promote inflammation.

How Gut Bacteria Affect Thyroid Hormones Directly

This is where it gets genuinely fascinating. Your gut bacteria don’t just influence the immune environment — they actively participate in thyroid hormone metabolism.

Enterohepatic Recycling of Thyroid Hormones

Your liver processes thyroid hormones (T3 and T4) by attaching molecules to them — a process called conjugation — before excreting them into bile. This bile enters the intestine, where gut bacteria can strip those molecules off again (a process called deconjugation), freeing the hormones to be reabsorbed.

This recycling loop — known as enterohepatic circulation — means that the composition of your gut microbiome directly affects how much active thyroid hormone is available in your bloodstream. If your microbiome is disrupted, this recycling process becomes less efficient, and you can end up with lower effective thyroid hormone levels even if your thyroid is producing adequate amounts.

The Conversion of T4 to T3

Most thyroid hormone produced by the thyroid gland is T4 (thyroxine) — a relatively inactive storage form. It must be converted into the active form, T3 (triiodothyronine), to have its effects. This conversion happens primarily in the liver, but also in the intestines, and is carried out by enzymes called deiodinases.

Research shows that gut bacteria can inhibit 5-deiodinase activity, reducing the conversion of T4 to T3. In other words, even if your thyroid is producing plenty of T4, poor gut health may mean you have inadequate levels of the active T3 hormone your cells actually need.

Butyrate: A Microbial Superstar for Thyroid Health

Butyrate is a short-chain fatty acid (SCFA) produced when beneficial gut bacteria ferment dietary fibre. It is the primary energy source for the cells lining your colon, and it has profound anti-inflammatory effects. In the context of the thyroid, butyrate produced by bacteria like Faecalibacterium prausnitzii has been shown to:

• Regulate expression of NIS — the protein that allows iodine into thyroid cells
• Inhibit enzymes (HDACs) that would otherwise suppress thyroid cell function
• Support the balance between pro- and anti-inflammatory immune cells (Treg/Th17 balance)
• Reinforce tight junctions in the gut lining

Other SCFAs — including propionate and acetate — also support immune regulation, particularly the generation of regulatory T cells (Tregs), which dampen autoimmune activity.

The practical implication? A high-fibre diet that feeds SCFA-producing bacteria is not just good for general gut health — it may directly support thyroid hormone production and immune regulation.

How Dysbiosis Drives Autoimmunity: The Mechanisms

In Hashimoto’s thyroiditis, the immune system mistakenly attacks thyroid tissue. How does gut dysbiosis contribute to this? There are several mechanisms:

1. Molecular Mimicry

Some gut bacteria have proteins that structurally resemble thyroid proteins — specifically thyroglobulin (Tg) and thyroid peroxidase (TPO), the very proteins targeted by antibodies in Hashimoto’s. When the immune system mounts a response to these bacterial proteins, it can accidentally begin attacking similar-looking thyroid proteins too. This is called molecular mimicry, and it has been demonstrated with bacteria including H. pylori.

2. Bystander Activation

Sometimes bacteria don’t directly trigger an autoimmune attack, but they stimulate immune cells (via antigen-presenting cells) into an overactivated state. These immune cells then attack whatever tissue is nearby or accessible — including the thyroid. This is called bystander activation, and it has been confirmed in experimental models of Hashimoto’s.

3. Inflammasome Activation

Gut bacteria and their metabolites can activate inflammatory complexes inside cells called inflammasomes — think of them as molecular alarm systems. In particular, the NLRP3 inflammasome is significantly over-expressed in the thyroid tissue of Hashimoto’s patients. When activated, it drives the release of inflammatory cytokines (chemical messengers) including IL-1β and IL-18 that perpetuate thyroid tissue damage.

4. LPS and Thyroid Disruption

When gram-negative bacteria release LPS — either due to dysbiosis or leaky gut — this molecule can directly affect the thyroid. Research has shown that LPS increases the expression of thyroglobulin and NIS genes in thyroid cells, activates inflammatory pathways (specifically TLR4-NF-κB), and alters the activity of deiodinase enzymes that convert thyroid hormones. High LPS levels in circulation are therefore a direct threat to thyroid homeostasis.

The Impact of Thyroid Dysfunction on the Gut

This relationship runs in both directions. Thyroid hormones are essential regulators of gut function, and when thyroid levels fall — as in hypothyroidism — the gut suffers noticeably.

• Gut motility slows: T3 is a primary regulator of intestinal epithelial cell development and the speed of gut contractions. Low T3 slows peristalsis, leading to constipation, bloating, and delayed gastric emptying.
• Bacterial overgrowth increases: Sluggish gut motility creates conditions where bacteria can proliferate in the small intestine, contributing to SIBO (Small Intestinal Bacterial Overgrowth) — a condition I work with extensively in my clinic.
• Microbiome composition shifts: Studies confirm that hypothyroid patients have significantly different gut microbiome compositions compared to healthy individuals.
• Low stomach acid: The thyroid supports adequate stomach acid production.
• Levothyroxine absorption impairs: Conditions like SIBO, IBD, and coeliac disease are associated with impaired absorption of levothyroxine (the synthetic T4 medication), which may explain why some patients need unusually high doses to maintain adequate thyroid levels.

Nutrients the Gut-Thyroid Axis Depends On

The gut is responsible for absorbing the micronutrients your thyroid cannot function without. Two are particularly critical:

Iodine

Iodine is the raw material your thyroid needs to build T3 and T4. It is absorbed in the small intestine via a transporter called NIS (sodium-iodide symporter). Your gut microbiome directly influences iodine availability: it regulates the enterohepatic cycling of iodine-containing compounds, and LPS from dysbiotic bacteria can alter NIS expression and activity. Both too little and too much iodine can trigger autoimmune thyroid disease — and your gut microbiome affects your exposure to both extremes.

Selenium

Selenium is essential for the deiodinase enzymes that convert T4 to active T3. The thyroid is the organ with the highest selenium concentration in the body. Selenium deficiency leads to impaired T3 conversion, increased oxidative damage to thyroid tissue, and worsened autoimmunity. Critically, Lactobacillus bacteria convert inorganic selenium into organic selenocysteine — a more bioavailable form. This means a healthy microbiome actively improves your selenium absorption.

Clinical trials have shown that selenium supplementation significantly reduces thyroid antibody levels (TPOAb and TgAb) in Hashimoto’s patients, and reduces the risk of developing overt hypothyroidism.

Other important micronutrients in the gut-thyroid axis include iron (needed for iodine utilisation), zinc (involved in TRH and TSH synthesis), and vitamin D (whose absorption is microbiome-dependent, and which helps regulate thyroid immune tolerance).

The Gut-Thyroid Axis and SIBO

SIBO deserves special mention here. When bacteria overgrow in the small intestine, they interfere with multiple aspects of the gut-thyroid axis simultaneously:

• They increase intestinal permeability, allowing LPS into circulation
• They disrupt bile acid metabolism, impairing enterohepatic recycling of thyroid hormones
• They compete for key micronutrients including iron, B12, and zinc
• They alter motility, creating a vicious cycle that perpetuates bacterial overgrowth

Research by Lauritano and colleagues found that patients with significantly decreased thyroid function are significantly more likely to have SIBO. Treating SIBO — with non-absorbable antibiotics like rifaximin, herbal antimicrobials, and microbiome restoration protocols — can improve thyroid hormone absorption and symptom burden.

Do You Have SIBO? Find Out Here.

Shop our gut health tests

Deoxycholic acid (DCA), a secondary bile acid produced by gut bacteria, has emerged as a potential marker of bacterial overgrowth in Hashimoto’s patients. Serum metabolomics research shows DCA is the predominant bile acid in HT, suggesting disrupted bacterial bile acid metabolism may be a key feature of the condition.

Related Digestive Conditions and Their Thyroid Links

The gut-thyroid connection extends to several specific digestive conditions worth being aware of:

Coeliac Disease: The molecular structure of gluten proteins resembles thyroid tissue. People with coeliac disease have significantly higher rates of Hashimoto’s than the general population. A gluten-free diet can reduce intestinal inflammation, improve absorption, and in some cases reduce levothyroxine requirements.

Helicobacter pylori Infection: H. pylori uses molecular mimicry to trigger thyroid autoimmunity. CagA-positive strains (more aggressive H. pylori variants) have nucleotide sequences similar to TPO — the enzyme antibodies in Hashimoto’s target. Meta-analyses confirm that CagA-positive H. pylori infection is significantly associated with autoimmune thyroid disease.

Autoimmune Atrophic Gastritis: Nearly 40% of patients with this condition also have Hashimoto’s thyroiditis. The reduced stomach acid in atrophic gastritis impairs iron absorption and compromises the synthesis of T3 and T4.

What You Can Do: Therapeutic Strategies

The good news is that by understanding the gut-thyroid axis, we have new and genuinely meaningful intervention targets. Here is what the current evidence supports:

1. Address SIBO and Bacterial Overgrowth

Testing for and treating SIBO is often the most impactful step for people whose thyroid symptoms persist despite medication. Rifaximin (a non-absorbable antibiotic) has robust evidence for SIBO eradication and has been shown to favour beneficial bacteria including Bifidobacterium and Faecalibacterium prausnitzii.

2. Restore the Microbiome with Diet, Lifestyle and Precision Probiotics and Prebiotics

Lactobacillus and Bifidobacterium species support barrier integrity, reduce inflammation, improve selenium bioavailability, and — in the context of Graves’ disease — have been shown to reduce thyroid antibody levels when combined with medication. Akkermansia muciniphila supports mucus layer thickness and tight junction integrity.

Prebiotics — non-digestible fibres that feed beneficial bacteria — increase SCFA production and support the Treg/Th17 immune balance critical in autoimmune thyroid conditions.

3. Optimise Diet

• Autoimmune Protocol (AIP) diet: A structured elimination approach that removes foods likely to trigger intestinal inflammation and dysbiosis. A pilot study in Hashimoto’s patients showed significant improvements in quality of life and inflammatory markers.
• Mediterranean diet: Rich in polyphenols and omega-3 fatty acids, the Mediterranean diet has strong evidence for reducing oxidative stress in thyroid conditions.
• High-fibre foods: Dietary fibre is the substrate for SCFA production. Vegetables, legumes, oats, and resistant starches all support butyrate-producing bacteria.
• Fermented foods: Support microbial diversity and immune tolerance.

4. Address Micronutrient Deficiencies

• Selenium: 100–200mcg/day of selenomethionine has been shown to reduce TPOAb and TgAb levels, and is generally well-tolerated. Testing is recommended before supplementing.
• Vitamin D: Deficiency is strongly associated with Hashimoto’s risk, and supplementation has been shown to reduce thyroid antibodies and TSH.
• Iodine: Needs careful management — both deficiency and excess are problematic. Assessment of iodine status is advisable before supplementing.
• Iron and Zinc: Important for iodine utilisation and thyroid hormone synthesis respectively.

5. Consider Gut-Targeted Functional Testing

Identifying what is actually happening in your gut is essential before implementing interventions. Guessing is inefficient, and the wrong approach can make things worse. Testing can identify:

• Bacterial overgrowth (SIBO breath testing — hydrogen and methane)
• Microbial imbalances and diversity
• Markers of intestinal permeability (e.g., zonulin)
• SCFA-producing bacterial populations
• Pathogenic bacteria, including H. pylori

Want To Know What's Going On In Your Gut?

Shop our gut health tests

A Note on Individual Variation

One of the most important points I want to make is that the gut microbiome is deeply individual. Two people with Hashimoto’s may have very different microbial profiles, different bacterial overgrowths, different nutrient deficiencies. This is why a one-size-fits-all approach to thyroid health — or gut health — rarely works.

Precision testing, individualised interpretation, and targeted intervention is the approach I take with every client. It’s slower than handing out a generic probiotic and hoping for the best, but it’s the approach that consistently gets results.

Summary: Key Takeaways

• The gut-thyroid axis is a bidirectional relationship between your intestinal barrier, gut microbiome, and thyroid function.
• Leaky gut allows inflammatory molecules (especially LPS) into the bloodstream, disrupting thyroid hormone production and fuelling autoimmunity.
• Dysbiosis reduces SCFA-producing bacteria, impairs thyroid hormone recycling and conversion, and alters immune regulation.
• SIBO is significantly more common in people with thyroid dysfunction and compounds gut-thyroid disruption in multiple ways.
• Key nutrients — iodine, selenium, iron, zinc, vitamin D — depend on gut integrity and microbial activity for optimal absorption.
• Evidence-based interventions — SIBO treatment, probiotics, prebiotics, dietary modification, and targeted supplementation — can meaningfully support thyroid function by addressing root causes in the gut.

If you have a thyroid condition and you haven’t yet looked at your gut health, this is where I’d start.

References

1. Zhu X, Zhang C, Feng S, He R, Zhang S. Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis. Clin Exp Med. 2024;24(1):39. PMID: 38386079. doi:10.1007/s10238-024-01304-4
2. Acampora L, Restolfer F, De Pierro P, Masulli M, Dentice M, Sarnelli G, Cicatiello AG. The gut-thyroid axis: physiological regulation of barrier function, microbiota, endocrine signaling and the consequences on energy metabolism. Front Physiol. 2026;17:1753136. doi:10.3389/fphys.2026.1753136
3. Virili C, Centanni M. “With a little help from my friends” — the role of microbiota in thyroid hormone metabolism and enterohepatic recycling. Mol Cell Endocrinol. 2017;458:39-43. PMID: 28111264
4. Knezevic J, Starchl C, Tmava Berisha A, Amrein K. Thyroid-gut-axis: how does the microbiota influence thyroid function? Nutrients. 2020;12(6):1769. PMID: 32545596
5. Zhao F, et al. Alterations of the gut microbiota in Hashimoto’s thyroiditis patients. Thyroid. 2018;28(2):175-186. PMID: 29320965
6. Ishaq HM, et al. Molecular estimation of alteration in intestinal microbial composition in Hashimoto’s thyroiditis patients. Biomed Pharmacother. 2017;95:865-874. PMID: 28903159
7. Gong B, et al. Association between gut microbiota and autoimmune thyroid disease: a systematic review and meta-analysis. Front Endocrinol. 2021;12:774362. PMID: 34925224
8. Lauritano EC, et al. Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab. 2007;92(11):4180-4184. PMID: 17698907
9. Cayres LCdF, et al. Detection of alterations in the gut microbiota and intestinal permeability in patients with Hashimoto thyroiditis. Front Immunol. 2021;12:579140. PMID: 33679750
10. Demir E, et al. The relationship between elevated plasma zonulin levels and Hashimoto’s thyroiditis. Turk J Med Sci. 2022;52(3):605-612. PMID: 36326386
11. Guo Q, et al. Cytokine secretion and pyroptosis of thyroid follicular cells mediated by enhanced NLRP3, NLRP1, NLRC4, and AIM2 inflammasomes are associated with autoimmune thyroiditis. Front Immunol. 2018;9:1197. PMID: 29915582
12. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91(1):151-175. PMID: 21248165
13. Huwiler VV, et al. Selenium supplementation in patients with Hashimoto thyroiditis: a systematic review and meta-analysis of randomized clinical trials. Thyroid. 2024;34(3):295-313. PMID: 38174551
14. Liu J, et al. Serum metabolomic patterns in patients with autoimmune thyroid disease. Endocr Pract. 2020;26(1):82-96. PMID: 31085985
15. Plateroti M, Kress E, Mori JI, Samarut J. Thyroid hormone receptor alpha1 directly controls transcription of the beta-catenin gene in intestinal epithelial cells. Mol Cell Biol. 2006;26(8):3204-3214. PMID: 16581796
16. Watanabe M, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439(7075):484-489. PMID: 16400329
17. Shi WJ, et al. Associations of Helicobacter pylori infection and cytotoxin-associated gene A status with autoimmune thyroid diseases: a meta-analysis. Thyroid. 2013;23(10):1294-1300. PMID: 23750814
18. Abbott RD, Sadowski A, Alt AG. Efficacy of the autoimmune protocol diet as part of a multi-disciplinary, supported lifestyle intervention for Hashimoto’s thyroiditis. Cureus. 2019;11(4):e4556. PMID: 31275780
19. Thomas RL, et al. Vitamin D metabolites and the gut microbiome in older men. Nat Commun. 2020;11(1):5997. PMID: 33239633
20. Chahardoli R, et al. Can supplementation with vitamin D modify thyroid autoantibodies (anti-TPO Ab, anti-Tg Ab) and thyroid profile (T3, T4, TSH) in Hashimoto’s thyroiditis? A double blind, randomized clinical trial. Horm Metab Res. 2019;51(5):296-301. PMID: 30965380